Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Pbyi Stock Analysis Puma Biotechnology Inc Holds 6.9 Level After 2.07 Pct Gain 20260403 1 Cxw Stock Analysis Corecivic Inc. Rises 1.16 Percent To 19.13 Amid Stable Private Corrections Trends 20260401 1 Will Inspire Insp Stock Fall Further Price At 54.42 Up 0.52 20260407 Is Fs Kkr Fsk Stock Testing Resistance Price At 10.73 Up 2.09 20260406 Is Connectone Cnob Stock Tied To Economic Cycles Price At 28.06 Down 0.21 20260413 PPIH PermaPipe International Holdings Inc posts 337 percent Q1 2026 EPS beat yet shares drop 628 percent today The shareholder friendly policies at Barrick B GOLD Q4 2025 Earnings Barrick Surprises With 14 EPS Beat Apellis APLS Stock Medium Term Trade Consolidates 20260415 Market Pulse Tech leads moderate gains as consumer groups lag behind Security Incident Targeting Leading Generative AI Executive Sector Risk and Stakeholder Implications Public Service Enterprise Group PEG Environmental Leadership Strengthens LongTerm Investment Thesis Through Landmark Wetlands Restoration United UBFO Stock Is It Worth Opening a Position United reports 019 EPS on steady lending growth Carpenter CRS Stock Recovery Underway Dormant 20260420 The current market environment presents several notable technical and sentiment extremes that merit careful consideration by investors DVS Dolly Varden shares drop 648 following Q4 2025 earnings miss that far undercut consensus analyst expectations MAR Marriott International Q4 2025 EPS misses consensus estimates by 22 triggering a mild 03 singleday stock dip Why are smart money investors paying attention to First US FUSB Smart Money Flows 20260508 The hidden strength in Columbus Acq COLA most investors miss Investors Pile In 20260508 What lagging indicators Telix TLX Breakdown Watch 20260427 US Stocks Slide as TrumpXi Summit Leaves Markets Underwhelmed by Lack of Concrete Trade Breakthroughs Regional Management RM Down 252 How Low Could It Go 20260515 Cerebras Systems Shares Slip 10 Following Strong Market Debut Should You Sell MIRA Pharmaceuticals MIRA After 124 Drop 20260515 Compugen CGEN Stock Today Rallies 070 Resistance at 301 20260514 Trumps Approval Rating Slips to 35 as Republican Support Erodes Schaeffler India Deepens IndustryAcademia Collaboration with New Facility at IISc BitFuFu FUFUW Stalls at 017 Breakout or Breakdown 20260515 AEW Collision Draws Attention Ahead of Potential Media Rights Renewal with FTR Title Defense Intuit Slides on Job Cuts elf Beauty to Lower Prices as Earnings Season Highlights Consumer and AI Trends Avidia AVBC Q1 2026 Beat Revenue NA EPS Exceeds by Significant Perimeter PRM Q1 2026 Earnings Why the Beat Matters European Stocks Hit Highest Level Since March 2 as USIran Talks Progress Nikkei Breaches 65000 SpaceX Postpones Starship Launch Amid Anticipated RecordBreaking IPO Most Undervalued Major Cryptos Heading Into Mid2026 Gold Prices Hover Near 4500 as IranUS Peace Talks Take Center Stage Inherited 401k Rules Failing to Follow Withdrawal Guidelines Could Trigger a 25 IRS Penalty WPP Q4 2025 Earnings EPS Beats Estimates Shares Edge Higher Amid Cautious Ad Market Rollins Inc ROL Q1 2026 Earnings EPS Edges Past Estimates Shares Dip Slightly FET Q1 2026 Earnings EPS Beats Estimates Amid Cost Discipline Stock Declines HEI Q4 2025 Earnings EPS Beat Amid Modest Stock Reaction FDBC Q4 2025 Earnings Solid EPS Performance Amidst Limited Guidance ENI SpA E Faces Pressure Testing Key Support After 18 Decline Fusion Fuel Green HTOO Dips Nearly 5 as Pressure Builds at Key Support McKinley Acquisition Corporation Rights MKLYR Surges 40 Rights Trading at 014 Mercer International Inc MERC Tests Critical Support After Nearly 5 Decline Ally Financial ALLY Holds Steady Near 43 as Volume Signals Cautious Optimism New Pacific Metals NEWP Holds Steady Near Support as Traders Eye Resistance Scully Royalty Ltd SRL Holds Steady at 612 as Traders Eye Key Resistance Old Republic International ORI Slips 132 as Defensive Sectors Face ProfitTaking Maze Therapeutics MAZE Holds Steady Near Resistance as Consolidation Continues